| Typ : |
Zeitung |
| Internet-Link : |
https://doi.org/10.1007/s40259-019-00342-9 |
|
| Forschungsgruppen : |
Grenade - Faculty of Science, Department of Analytical Chemistry |
| Autoren : |
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
| Titel : |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). |
| Veröffentlichung : |
Bio Drugs ; 33: 193–205. 2019 |
|
| Niveau von Beweisen : |
|
| physikalische Stabilität : |
|
| chemische Stabilität : |
|
| andere Verfahren : |
|
| Kommentare : |
| Proteine: biologische Aktivität mittels Zellkultur |
|
Molekülverzeichnis
 Infliximab
|
 |
 |
 |
 |
10 mg/ml |
2-8°C |
 |
| 14 |
 |
|
|
|
|
|
10 mg/ml |
2-8°C |
|
| 14 |
|
|
 |
|
 |
 |
0,4 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
| 14 |
|
|
|
|
|
